Adam Havey, EVP, Biodefense Divison at Emergent BioSolutions Inc. (EBS), sold 23,502 shares at $33.84 ($796K) on 2016-03-11, disclosed to the SEC on 2016-03-15.
Seasonal sale ($796k) by EVP, Biodefense Divison — this insider has traded EBS in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.84 | 3,152 | $107K | 13.4% |
| 2 | $33.84 | 3,152 | $107K | 13.4% |
| 3 | $33.84 | 7,960 | $269K | 33.8% |
| 4 | $33.84 | 7,960 | $269K | 33.8% |
| 5 | $34.22 | 1,278 | $44K | 5.5% |
| Total | $33.86 avg | 23,502 |
| $796K |
| 100% |
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |